Mylotarg™ (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

Francis J. Giles, Hagop M. Kantarjian, Steve M. Kornblau, Deborah A. Thomas, Guillermo Garcia-Manero, Tracey A. Waddelow, Cynthia L. David, Alexandria T. Phan, Dawn E. Colburn, Asif Rashid, Elihu H. Estey

Research output: Contribution to journalArticlepeer-review

233 Scopus citations

Fingerprint

Dive into the research topics of 'Mylotarg™ (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences